Enovis CORP (ENOV) stock
ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)
Close on Nov 18, 2026Market cap $1.56BP/E –Yield –
Enovis r&d expenses
Research and development expenses are spending on new products and technology.
Enovis's R&D Expenses for the twelve months ending Jul 3, 2026 was $124.32M, up 19.9% year over year. For fiscal 2025 it was $120.33M, up 31.8% from the year before. The highest annual figure on record is $120.33M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $120.33M | +31.8% |
| FY2024 | Dec 31, 2024 | $91.30M | +21.2% |
| FY2023 | Dec 31, 2023 | $75.33M | +23.8% |
| FY2022 | Dec 31, 2022 | $60.83M | +23.9% |
| FY2021 | Dec 31, 2021 | $49.09M | +43.3% |
| FY2020 | Dec 31, 2020 | $34.27M | +500.5% |
| FY2011 | Dec 31, 2011 | $5.71M | -8.0% |
| FY2010 | Dec 31, 2010 | $6.21M | +4.6% |
| FY2009 | Dec 31, 2009 | $5.93M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jul 3, 2026 | $31.69M | +3.2% |
| Q1 FY2026 | Apr 3, 2026 | $31.53M | +10.5% |
| Q4 FY2025 | Dec 31, 2025 | $31.37M | +31.0% |
| Q3 FY2025 | Oct 3, 2025 | $29.74M | +45.1% |
| Q2 FY2025 | Jul 4, 2025 | $30.70M | +30.8% |
| Q1 FY2025 | Apr 4, 2025 | $28.53M | +22.0% |
| Q4 FY2024 | Dec 31, 2024 | $23.95M | +30.7% |
| Q3 FY2024 | Sep 27, 2024 | $20.49M | +3.0% |
| Q2 FY2024 | Jun 28, 2024 | $23.48M | +24.1% |
| Q1 FY2024 | Mar 29, 2024 | $23.38M | +28.5% |
| Q4 FY2023 | Dec 31, 2023 | $18.32M | +24.4% |
| Q3 FY2023 | Sep 29, 2023 | $19.90M | +27.6% |
| Q2 FY2023 | Jun 30, 2023 | $18.92M | +20.8% |
| Q1 FY2023 | Mar 31, 2023 | $18.19M | +22.6% |
| Q4 FY2022 | Dec 31, 2022 | $14.73M | -3.3% |
| Q3 FY2022 | Sep 30, 2022 | $15.60M | +25.2% |
| Q2 FY2022 | Jul 1, 2022 | $15.66M | +41.9% |
| Q1 FY2022 | Apr 1, 2022 | $14.84M | -25.4% |
| Q4 FY2021 | Dec 31, 2021 | $15.23M | -9.3% |
| Q3 FY2021 | Oct 1, 2021 | $12.46M | -11.6% |
| Q2 FY2021 | Jul 2, 2021 | $11.04M | -40.3% |
| Q1 FY2021 | Apr 2, 2021 | $19.90M | +22.1% |
| Q3 FY2020 | Oct 2, 2020 | $16.80M | -48.5% |
| Q2 FY2020 | Jul 3, 2020 | $14.10M | – |
| Q1 FY2020 | Apr 3, 2020 | $18.50M | – |
| Q3 FY2019 | Sep 27, 2019 | $16.30M | – |
| Q2 FY2019 | Jun 28, 2019 | $32.60M | – |
See a number that looks wrong?